GlaxoSmithKline (NYSE: GSK) will team up with public/private group the Union for Epidemic Preparedness Innovations (CEPI) to assist establish a vaccine against 2019- nCoV, the coronavirus triggering the current break out. It will make its vaccine adjuvant platform innovation, currently utilized effectively in a pandemic flu setting, available for a potential vaccine.
CEPI will coordinate activities in between GSK and entities moneyed by CEPI. The very first agreement has actually been signed between GSK and the Univer